PLI Scheme for Promotion of Domestic Manufacturing of Critical KSMs, Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs)
Background and Context Quick Facts Objectives Salient Features (a) Bulk Drug or API (b) Scope of the Scheme (c) Eligible Investment Subsidy is linked to actual investment made in: Target Segments The scheme identifies two major routes of manufacturing: Financial Incentives Why is it Important? ✅ In summary: This PLI scheme is about securing India’s…
